Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - non biologic treatment and small molecules
THU0109 Lack of Efficacy of CCR1 Antagonist BMS-817399 in Patients with Moderate to Severe Rheumatoid Arthritis: Results of 12-Week Proof-Of-Concept Study
Compose a Response to This Article
Other responses
No responses have been published for this article.